When a number of issues such as the One Million Women study for HRT and recent pill crisis for hormonal contraceptives shook women’s trust in hormones, the gynaecological market dropped significantly. This fall in demand was matched by the flight of some big pharmaceutical manufacturers from gynaecology medication. This allowed smaller companies like Gedeon Richter France to establish themselves as a true partner in gynaecology.
Webcode:
To read an article from the print magazine online, please enter the web code below, which can be found in the magazine under the article.
